C20H25NO4
Neat
343.42
6a-Naltrexol; 20410-98-4; Naltrexone-6-alpha-ol; CHEMBL468469; Naltrexone impurity 31; (4R, 4aS, 7S, 7aR, 12bS)-3-(cyclopropylmethyl)-1, 2, 4, 5, 6, 7, 7a, 13-octahydro-4, 12-methanobenzofuro[3, 2-e]isoquinoline-4a, 7, 9-triol; 6?-Naltrexol (1.0mg/ml in Acetonitrile); 6 alpha-hydroxynaltrexone; 6?-NALTREXOL; Morphinan-3, 6, 14-triol, 17-(cyclopropylmethyl)-4, 5-epoxy-, (5a, 6a)-; Morphinan-3, 6a, 14-triol, 17-(cyclopropylmethyl)-4, 5a-epoxy- (8CI); 6a-Hydroxynaltrexone; 6a-Naltrexol; EN 2260; a-Naltrexol; I+/-lpha-Naltrexol; SCHEMBL679581; DTXSID30942580; BDBM50254511; FN26130; (4R, 4aS, 7S, 7aR, 12bS)-3-(cyclopropylmethyl)-1, 2, 3, 4, 5, 6, 7, 7a-octahydro-4aH-4, 12-methanobenzofuro[3, 2-e]isoquinoline-4a, 7, 9-triol; (5a, 6a)-17-(Cyclopropylmethyl)-4, 5-epoxy-morphinan-3, 6, 14-triol;17-(Cyclopropylmethyl)-4, 5a-epoxy-morphinan-3, 6a and 14-triol;a-Naltrexo l
(4R, 4aS, 7S, 7aR, 12bS)-3-(cyclopropylmethyl)-1, 2, 4, 5, 6, 7, 7a, 13-octahydro-4, 12-methanobenzofuro[3, 2-e]isoquinoline-4a, 7 and 9-triol
InChI=1S/C20H25NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,14-15,18,22-24H,1-2,5-10H2/t14-,15+,18-,19-,20+/m0/s1